Study: Presence of sales reps influences coronary stent selection, price

August 30, 2013 by Brian Johnson

The presence of a sales rep can increase the per-case price of stenting by as much as $230, according to a study in the American Heart Journal.

regular_taxus_stent_fda.jpg

A sales rep's visit could be worth as much as $230 per case in surgeons' use of coronary stents, according to a study in the American Heart Journal. The presence of a company sales rep in the cath lab increased the likelihood that surgeons would opt for drug-eluting over bare-metal stents, researchers said.

The study, aimed at understanding the impact and influence of sales reps in PCI cases, examined the selection of stents in 1,145 patients over a 12-month period from 2008-2009.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp